Palmitoylethanolamide (PEA) reduces inflammation in cardiomyocytes and endothelial cells exposed to doxorubicin and trastuzumab through PPAR-a and NLRP3

Back

HFA Premium Access

Palmitoylethanolamide (PEA) reduces inflammation in cardiomyocytes and endothelial cells exposed to doxorubicin and trastuzumab through PPAR-a and NLRP3

Session: Heart Failure ePosters - focus on Comorbidities and special population

Topic: Cardio-Oncology

Speaker: Doctor V. Quagliariello (Naples, IT)

Event: Heart Failure 2022

Congress Presentation

Add to my library

About the speaker

Doctor Vincenzo Quagliariello

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)

0 follower

35 more presentations in this session

A brazilian perspective about the impact of covid 19 on hospitalizations for venous tromboembolism and pulmonary embolism

Speaker: Mr E. Biscarde (BR)

Access

Abstract

Slides

Diastolic disfunction in precapillary pulmonary hypertension - looking left to see right

Speaker: Doctor P. Alves da Silva (Lisbon, PT)

Access

Abstract

Slides

Pulmonary hypertension in connective tissue diseases with overt of features of venous/capillaries involvement: clinical implications and prognostic impact of this phenotype.

Speaker: Doctor J. Grade Santos (Almada, PT)

Access

Abstract

Slides

Risk stratification in pulmonary arterial hypertension: do our patients benefit from a 4-strata model?

Speaker: Doctor J. Grade Santos (Almada, PT)

Access

Abstract

Slides

Comparison of risk scores calculators in patients newly diagnosed with pulmonary arterial hypertension.

Speaker: Doctor J. Grade Santos (Almada, PT)

Access

Abstract

Slides

Access the full session

Heart Failure ePosters - focus on Comorbidities and special population

Speakers: Doctor V. Quagliariello, Mr E. Biscarde, Doctor P. Alves da Silva, Doctor J. Grade Santos, Doctor J. Grade Santos...

Access

About the event

Heart Failure 2022

21 May - 24 May 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources